MRC Confidence in Concept Fund

The Tropical Infectious Disease Consortium is managing a MRC Confidence in Concept Award 2018 of £590,000 which can be allocated to individual projects that accelerate the transition from discovery science into therapeutic, diagnostic and vaccine development.  

 

 


The partners of the Consortium,  LSTM; the London School of Hygiene and Tropical Medicine; The Jenner Institute at Oxford University and Public Health England Microbiology Research Services in Porton Down, will jointly provide awards of up to £50,000 and allocate to eligible project proposals via an open, competitive and externally peer reviewed process.

‘The overarching aim of the consortium is to support preliminary work or feasibility studies which establish the viability of the approach and thereby accelerate the development of the solution’, says Giancarlo Biagini, Professor of Parasitology at LSTM, Senior Manager within the Consortium and the Research Centre for Drugs & Diagnostics (RCDD).

‘Following receipt of CiC awards, we would expect the projects to be competitive for more substantive funding such as MRC DPFS awards’, he continued.

Projects within the following categories will be eligible to apply:

    • Diagnostics
    • Therapeutics
    • Vaccines
    • Vector control tools
    • Translational focussed Informatics
    • Translational enabling technologies 

Eligible projects should be at the stage where allocated funding by the Consortium would develop the approach to the next level where it would be capable of successfully applying to larger external translational funding sources. It is the objective of the Tropical Infectious Disease Consortium to create a critical mass necessary for UK researchers who are interested in translating their research into health benefits, which will support them in an increasingly competitive international market. The aim is to support a high number of scientifically excellent translational proposals.

Applications are required to have a Principal Investigator from one of the Consortium’s partner institutions and projects from more than one of the partner institutions are encouraged.  Applications with SMEs/Pharma will attract a higher weighting within the scoring process, but these must be led by the academic PI.

++ The application process for 2018 is now CLOSED ++

It is anticipated that decisions on awards will be issued in June 2018.

More information, including list of selection criteria, scoring methodology can be found here and here

Results of the successful 2017 applications can be found here.